Showing results (251-260 of 552) with videos related to
Sort By:
Pageof 56
Drugs|May 23, 2014
Next-generation phosphate binders: focus on iron-based bindersDimitra Nastou, Beatriz Fernández-Fernández, Usama Elewa, et al.Current Medicinal Chemistry|February 17, 2010
Tyrphostins as potential therapeutic agents for acute kidney injuryS Gonçalves, R Fernandez-Sanchez, M D Sanchez-Niño, et al.European Geriatric Medicine|August 12, 2025
Towards a core outcome set for sarcopenia intervention studies: a scoping review identifying the most frequently reported outcomes across randomized controlled trials in sarcopeniaS Van Heden, Y M Chan, Z Baoubbou, et al.International Journal of Molecular Sciences|September 30, 2014
Sildenafil attenuates inflammation and oxidative stress in pelvic ganglia neurons after bilateral cavernosal nerve damageLeah A Garcia, Su M Hlaing, Richard A Gutierrez, et al.Plos Pathogens|May 26, 2026
Outer membrane vesicles hijack TIM-1 for cellular uptakeCraig R MacNair, Varnesh Tiku, Shengya Cao, et al.The Journal of Emergency Medicine|February 1, 2022
Not All Testers are Admitters: An Analysis of Emergency Physician Resource Utilization and Consultation RatesPeter S Antkowiak, Terrance Lee, David T Chiu, et al.Journal of Medicinal Chemistry|December 1, 1981
3-Phenylpiperidines. Central dopamine-autoreceptor stimulating activityU Hacksell, L E Arvidsson, U Svensson, et al.Journal of Medicinal Chemistry|August 1, 1984
C1-Methylated 5-hydroxy-2-(dipropylamino)tetralins: central dopamine-receptor stimulating activityU Hacksell, A M Johansson, L Arvidsson, et al.Cytokine & Growth Factor Reviews|May 28, 2014
CXCL16 in kidney and cardiovascular injuryMaría Concepción Izquierdo, Catalina Martin-Cleary, Beatriz Fernandez-Fernandez, et al.International Journal of Molecular Sciences|November 14, 2023
Interaction of Fabry Disease and Diabetes Mellitus: Suboptimal Recruitment of Kidney Protective FactorsMaria D Sanchez-Niño, Maria I Ceballos, Sol Carriazo, et al.Pageof 56